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Abstract A biofunctionalized reduced graphene oxide (rGO)-modified screen-printed carbon
electrode (SPCE) was constructed as an immunosensor for C-reactive protein (CRP) detection,
a biomarker released in early stage acute myocardial infarction. A different approach of single
frequency analysis (SFA) study was utilized for the biomolecular sensing, by monitoring the
response in phase angle changes obtained at an optimized frequency resulting from antigen-
antibody interactions. A set of measurements were carried out to optimize a frequency where a
maximum change in phase angle was observed, and in this case, we found it at around 10 Hz.
The bioelectrode was characterized by contact angle measurements, scanning electron micros-
copy, and electrochemical techniques. A concentration-dependent response of immunosensor
to CRP with the change in phase angle, at a fixed frequency of 10 Hz, was found to be in the
range of 10 ng mL−1 to 10 μg mL−1 in PBS and was fit quantitative well with the Hill-
Langmuir equation. Based on the concentration-response data, the dissociation constant (Kd)
was found to be 3.5 nM (with a Hill coefficient n = 0.57), which indicated a negative
cooperativity with high anti-CRP (antibody)-CRP (antigen) binding at the electrode surface.
A low-frequency analysis of sensing with an ease of measurement on a disposable
electroactive rGO-modified electrode with high selectivity and sensitivity makes it a potential
tool for biological sensors.
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Introduction
C-reactive protein (CRP) is a pentameric plasma protein with molecular weight 118 kDa,
and is considered to be a valuable marker of inflammation indicating incident myocardial
infarction, stroke, and sudden cardiac death [1–3]. The American Heart Association has
suggested three different CRP concentration levels in human blood serum to evaluate the
cardiovascular disease risk: a low-risk state for CRP concentrations less than 1 μg mL−1,
an average risk state for CRP concentrations between 1 and 3 μg mL−1, and high-risk state
for any concentration above 3 μg mL−1 [4, 5]. Thus, early quantification of CRP concen-
tration is crucial for accurate and timely therapeutic interventions both before and after the
occurrence of AMI in patients. Currently, a number of clinical CRP testing methods are
available, such as nephelometric [6], turbidimetric [7], and the enzyme-linked immuno-
sorbent assay (ELISA) kits [8]. However, these methods have many disadvantages of time-
consuming, multi-steps, expensive, and require trained personnel [9]. Other methods of
CRP quantification based on surface plasmon resonance (SPR) [10], fluorescence [11],
and electrochemistry [12] have been reported during the past few years. Among these,
electrochemical assay offers the advantage of low cost and high sensitivity. Recently, a
number of CRP assays have been reported by electrochemical impedance spectroscopy
(EIS) [13–16]. In EIS, a small amplitude AC signal is applied to the electrode in a wide
frequency range and measures the corresponding impedance, which has been extensively
used in the past to the sensors for wide applications [17–19]. In an EIS biosensor, any
biorecognition event is reflected by a change in impedance parameters, e.g., charge
transfer resistance (Ret), capacitance (Cdl), and phase angles (−Φ) that can be used for
the detection of biomolecules. The measurement of impedance over a wide frequency
range is time consuming, especially if it involves a low-frequency range. Single frequency
impedance analysis is an EIS technique where a single frequency is used as an excited
signal instead of wide frequency range sweep to reduce the complexity in signal acquisi-
tion and its processing, which makes it a suitable, simple and inexpensive analysis
technique. Thereby, it has a great ability of a fast response, low cost, and low power
analysis with an ease of measurement for both the clinical and on field assays.
Several biosensors have been reported recently on screen-printed carbon electrodes
(SPCEs) because of its advantages of simplicity, cost-effectiveness, portability, mass produc-
tion capabilities and disposable nature [20–22]. However, SPCE biofunctionalization is still a
critical factor, which requires further improvement through surface modification of SPCE with
other electroactive materials. Recent advances in nanomaterials have offered the possibility to
further improve the sensing performance of the biosensors in terms of sensitivity and wide
range of biomolecular detection [23–25]. Graphene, a two-dimensional nanomaterial having
the properties of high surface area, strong mechanical strength, excellent electrical conductiv-
ity, and biocompatibility, is a choice for the fabrication of stable and highly sensitive
biosensors for the detection of a various analytes [26–30]. Although, several publications have
appeared on graphene for sensor applications, no one has yet reported a single low-frequency
impedance analysis on rGO-modified SPCE for biomolecular detection of CRP.
In this work, we report a biofunctionalized rGO-modified SPCE as disposable
immunosensor and single frequency impedance analysis technique was applied for the
low cost, fast, sensitive, and selective detection of C-reactive protein. The rGO/SPCE
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was biofunctionalized with a protein antibody, anti-CRP, via a bilinker, 1-pyrenebutyric
acid N-hydroxy succinimide ester (PyNHS) utilizing carbodiimide cross-linking reaction
to form the anti-CRP-PyNHS/rGO/SPCE. The surface and electrochemical characteriza-
tion of the immunosensor was done by contact angle measurement, scanning electron
microscopy (SEM), cyclic voltammetry, and EIS technique. The analytical characteristic
of the immunosensor towards CRP was studied by measuring the phase shift, as an
elemental tool, in a single frequency impedance analysis. The changes observed in the
phase angle in EIS at a fixed frequency showed a good correlation with CRP concen-
tration and thus provided a high sensitive and selective detection of CRP.
Material and Methods
Chemicals
CRP (Cat 8C72), anti-CRP (Cat 4C28), and myoglobin (Cat 8M50) were procured from
Hytest (Turku, Finland). PyNHS was procured from Sigma-Aldrich Corp. SPCEs were
purchased from CHI instruments, USA.
Methods
Preparation of the Bio-SPCE
The SPCE was first washed with distilled water and dried under N2 gas flow. The SPCE
was first modified with graphene oxide (GO) by drop casting a 5-μL homogeneous
suspension of GO (0.3 mg/mL) over the working electrode and dried at room tempera-
ture for overnight period. After that, it was annealed at 60 °C for 60 min to improve the
cohesiveness of GO. The GO/SPCE was then electrochemically reduced to rGO/SPCE
by running 10 successive cyclic voltammetry (CV) cycles within a window of 0 to
−1.4 V at a scan rate of 50 mV s−1 in 0.5 M KCl solution purged with N2 gas (Fig. 1).
The cathodic current peak at −1.4 V is due to the irreversible electrochemical reduction
of several oxygen-containing functional groups on the surface of GO [31]. A decrease in
the reduction peak with increasing CV scans to almost a disappearing state confirms a
near completion of the reduction of GO to rGO, as evident in Fig. 1. The rGO/SPCE was
finally washed with distilled water and dried under N2 gas flow. The rGO/SPCE was then
incubated with 2 μL of 6 mM PyNHS (in DMF) for 1 h at room temperature, washed
with DMF, and dried with N2 gas flow to obtain the PyNHS/rGO/SPCE through π-π
stacking. This was subsequently treated with 5 μL PBS containing 1 mg mL−1 anti-CRP
at 4 °C for 2 h, washed with PBS, and dried under N2 gas, to obtain the desired anti-
CRP-Py/rGO/SPCE (bio-SPCE). The bio-SPCE was then further treated with 0.1% (w/v)
bovine serum albumin (BSA) to passivate the non-specific binding sites of free esters at
bio-SPCE surface and was washed repeatedly with PBS to get rid of any physical
adsorption of anti-CRP, dried under N2 gas, and stored at 4 °C. The schematic represen-
tation of bio-SPCE fabrication is shown in Fig. 2.
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Results and Discussion
Surface Morphology Studies
Contact angle measurements were carried out to measure the hydrophilic/hydrophobic features
of the SPCE surface at each step of modification by static sessile drop method using
DSA0MK2 fromKruss GmbH, Germany. Digital snapshots of water droplets on SPCE surface
Fig. 2 Schematic representation of the stepwise fabrication of the bioelectrode
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Fig. 1 Electrochemical reduction of GO/SPCE in a deaerated solution of 0.5 M KCl at a scan rate of 50 mV s−1
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were taken and analyzed with Kruss software. Three replicate measurements were taken at
each modification step to establish the statistical significance. A contact angle of 108.3 ± 4°
obtained for SPCE surface corresponds to a hydrophobic feature. After the modification of
SPCE with GO, the contact angle reduces to 74.2 ± 3° (Fig. 3b) due to the presence of the
hydrophilic groups like –OH and –COOH present at GO surface. Thereafter, an electrochem-
ical reduction of GO/SPCE to rGO/SPCE increased the contact angle to 102.4 ± 3° (Fig. 3c).
This was further increased to 118.3 ± 5° (Fig. 3d) after the covalent biomolecular immobili-
zation of rGO/SPCE with anti-CRP, due to the hydrophobic backbone structure of the protein
molecules, which thereby confirmed the fabrication of bio-SPCE.
The surface morphological characterization of the rGO/SPCE with and without anti-CRP
was done by using SEM images taken from FE-SEM model SUPRA40 VP, Germany. The
surface morphologies of the rGO/SPCE and anti-CRP functionalized rGO/SPCE are shown in
Fig. 4. Figure 4a shows the rGO flakes are uniformly distributed throughout the electrode
surface with a porous and wrinkled structure. This highly porous and wrinkled nanostructure
of rGO has offered a large active surface area for the biomolecular immobilization of anti-CRP.
The appearance of small particulates with a few aggregates over the surface of rGO with a
homogeneous feature (Fig. 4b) showed an effective covalent immobilization of anti-CRP
indicating to a successful fabrication of bio-SPCE.
Fig. 3 Contact angle measurement images. a Bare SPCE. b GO/SPCE. c rGO/SPCE. d Anti-CRP-Py/rGO/
SPCE (bio-SPCE)
Fig. 4 SEM images. a rGO/SPCE. b anti-CRP-Py/rGO/SPCE
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Electrochemical Characterization of the Bioelectrode Fabrication
CV studies were carried during each step of surface modification leading to bio-SPCE
fabrication using PGSTAT302N, AUTOLAB instrument from Eco Chemie. All CV measure-
ments were performed on SPCE in PBS (pH 7.4; 0.1 M KCl) containing a mixture of 2 mM
K3[Fe(CN)6] and 2 mM K4[Fe(CN)6], as a redox probe, at a scan rate of 50 mV s
−1 (Fig. 5a).
The bare SPCE showed a reversible CV with a separation between oxidation and reduction
potentials (ΔEp) of 241 mV. A decrease in the redox peak current with ΔEp = 341 mV was
observed upon modification of SPCE with GO, showing a sluggish electron transfer charac-
teristic arises due to the two reasons: (i) GO is less electrical conductive because of oxidized
surface and (ii) electrostatic repulsion between the negatively charged species of [Fe (CN)6]
3−/4
− and oxygenated functional groups of GO. After the electrochemical reduction of GO to rGO,
the depletion in oxygen-containing moieties resulted to a redox couple of enhanced peaks
current with ΔEp = 147 mV, thereby confirming the formation of rGO/SPCE. The
electroactive surface area of rGO-modified working electrode of SPCE was determined by
using the Randles-Sevcik equation, Eq. 1 [32]:
Ip ¼ 2:69 105
 
n3=2 A D1=2 ν1=2 C ð1Þ
where Ip is the redox peak current in ampere, n is the number of electrons participated in redox
reaction, A is the electroactive surface area (cm2),D is the diffusion coefficient of K3[Fe(CN)6]
(cm2 s−1), C is the concentration of redox probe (mol cm−3), and ν is the scan rate (V s−1). The
rGO/SPCE surface exhibited a significant increase in electroactivity due to a twofold increase
in the electroactive surface area (0.135 cm2) to its geometric area (0.07 cm2). The modification
of rGO/SPCE with PyNHS causes a decrease in the redox current with an increased ΔEp
(343 mV) due to hydrophobic pyrene moiety that perturbed the electron transfer kinetics at the
electrode surface. This, upon subsequent immobilization with anti-CRP and passivation of the
non-specific sites with BSA, further increased the ΔEp = 620 mV with a slowdown in the
electron transfer kinetics due to insulating character of protein molecule, indicating the
formation of bio-SPCE.
Fig. 5 a CVof the bioelectrode at different stages of fabrication in PBS (0.1 M KCl; pH 7.4) containing 2 mM
[Fe(CN)6]
3−/4−; scan rate 50 mV s−1, third CV scan is shown. b Corresponding Bode plot. Inset: corresponding
Nyquist plot
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EIS was also performed to study the interfacial impedance characteristics of the bio-SPCE.
According to EIS, a Bode plot is composed of (i) a high-frequency region, (ii) a low-frequency
region, and (iii) a mid-frequency region describing the solution properties, the electron transfer
characteristics, and the electrode/solution interfacial capacitive properties, respectively. The
mid-frequency region is the region where voltage vs time (V/t) and current vs time (I/t) are not
in phase and are frequency dependent. Since all the faradic and non-faradic processes occur in
this mid frequency region, thus we take it as a region of interest in the present study. The
complex impedance possesses both the real (magnitude) and the imaginary (phase) part and
can be represented by Eq. (2)
Z
0 ¼ ZeiΦ ð2Þ
where the real part Z represents the amplitude of voltage to current ratio and Φ represents the
phase difference between the voltage and the current with time, and i is the imaginary unit.
Figure 5b shows the Bode plot of phase shift with logarithm frequency over the range of
0.01 Hz to 10 kHz taken during the fabrication of bio-SPCE. The maxima in the phase shift
(corresponding to capacitive reactance) of the rGO/SPCE increased and shifted to a lower
frequency region after a subsequent functionalization with a bilinker, PyNHS, and anti-CRP.
The rGO/SPCE showed a maximum phase angle of 58.4° at 5.2 Hz, which get shifted towards
a low-frequency of 0.7 Hz with an increase in the maximum phase angle to 63.4° after
biomolecular immobilization with anti-CRP, demonstrating the biocompatible feature of the
electrode. This is in conformity to a complementary study of charge transfer resistance (Ret) in
Nyquist plot obtained during bio-SPCE fabrication (Inset of Fig. 5b). The chi-squared function
(χ2) of the best fit equivalent circuit to the Nyquist and Bode plots is the measure of the
standard deviation between the original data and the calculated spectrum; this was found to be
1.89 for the bioelectrode, and the detail of other EIS characteristics parameters are given in
Table 1.
EIS Response of the Bio-SPCE to Target CRP
The formation of a complex between the biomolecular probe (antibody) and the complemen-
tary antigen molecule upon immunoreaction causes an increase in the phase angle of the
circuit. Therefore, a quantitative analysis of CRP can be performed by monitoring the changes
in the phase angle upon bio-recognition of different CRP concentrations, at the electrode
surface, at an optimized frequency. Frequency analysis study was performed on bio-SPCE,
both before and after incubation with target protein antigen, CRP, to find out an optimum
Table 1 CV and EIS characteristics parameters of SPCE at various stages of its surface modification
Type of electrodes ΔEp
(mV)
Ret
(Ω cm2)
CPE Y0 n
(μF cm−2)
k0 (m s−1)
(×10−5)
Zw (Ω cm
2)
(×10−5)
χ2
(×10−1)
(−Φ)
Bare SPCE 241 403.2 0.12 0.93 6.72 2.33 1.21 66.6
GO/SPCE 341 791.7 0.07 0.88 3.42 2.23 3.10 67.6
rGO/SPCE 147 286.3 13.2 0.87 9.46 2.78 4.33 57.9
PyBuNHS/rGO/SPCE 343 974.4 10.7 0.91 2.78 4.85 4.11 60.1
Anti-CRP-PyBu/rGO/SPCE 620 3570.2 3.5 0.80 0.75 2.85 1.89 63.2
ΔEp redox potential, Ret charge transfer resistance, CPE constant phase element, k0 apparent rate constant, Zw
Warburg impedance, −Φ highest phase angle
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frequency where a maximum shift in the phase angle was observed. The interaction of target
CRP to bio-SPCE was examined in a mixture of 0.1 M KCl and 2 mM [Fe(CN)6]
3−/4− in PBS
(0.1 M, pH 7.4). A complete scan of phase angle was performed for immunoreaction in a
frequency region of 10 kHz to 0.01 Hz at bio-SPCE surface. Figure 6a represents the
frequency-dependent phase angle Bode plot of the bio-SPCE before and after the bio-
reaction with 1.0 μg mL−1 CRP. Depending on maximum shift observed in the phase angle
at 10 Hz, it was chosen as an optimum frequency (inset Fig. 6a), for the concentration-
dependent phase angle analysis for CRP detection. Real-time SF impedance analysis was
carried out to characterize the binding affinity and the optimization of the bio-reaction time
required for the completion of immunoreaction between the bio-receptor and the CRP. For this
purpose, a 30 μL drop of 1 μg mL−1 target CRP analyte in a PB solution of 2 mM [Fe(CN)6]
3
−/4− was drop-casted on bio-SPCE and single frequency impedance phase analysis was carried
out, at 10 Hz, for 1200 s. The experimental results indicate that more than 90% saturation in
the phase angle was reached within 600 s (Fig. 6b) and thus a bio-reaction time of 600 s was
selected for CRP immunoassay.
The bio-SPCE response was evaluated from Δ (Φ) = Φa − Φb where Φb and Φa represent
the phase angles of the circuit before and after the incubation of bio-SPCE with varying
concentration of CRP, respectively. Figure 7 represents the CRP concentration-dependent
change in the phase angle of the circuit with error bars showing standard deviation of the
Fig. 6 a Bode plot of the bio-SPCE before and after incubation with 1 μg mL−1 CRP and the inset showing the
optimized frequency at which maximum phase shift occur upon interaction. b Single frequency real time
response of the bio-SPCE to 1 μg mL−1 CRP at 10 Hz. c SFA of the bio-SPCE for blank (pure PBS) and
10 μg mL−1 CRP. d Comparative SFA plot of the bio-SPCE for PBS and 1 μg mL−1 CRP; and the inset (upper
left) shows a comparative response of bio-SPCE to 0.01 μg mL−1 CRP with PBS and (upper right) to non-
specific 1 μg mL−1 Mb with PBS, respectively
Appl Biochem Biotechnol (2017) 183:672–683 679
mean. The concentration-dependent response fitted well with a Hill-Langmuir equation (Eq. 3)
model for equilibrium binding between the bio-receptor and the target antigen [33].
ΔΦ ¼ A
c
Kd
 n
1þ cKd
 n þ Z ð3Þ
where c, A, Z, Kd, and n correspond to a CRP concentration, bio-SPCE response having all the
binding sites occupied, an offset showing pure buffer response, a dissociation constant
revealing a CRP concentration at which half of the binding sites are occupied, and a Hill
coefficient accounting the antibody-antigen binding cooperativity, respectively. The curve was
fitted to the Hill-Langmuir equation by keeping the maximum response A constrained to a bio-
SPCE response (A = 5.6) and others parameters Z, Kd, and n were allowed to vary. It was best
fitted with the parameters Kd = 414 ± 269 ng mL
−1, Z = 0.69 ± 0.45, and n = 0.57 ± 0.07. The
low Kd value of 3.5 nM revealed a strong binding affinity of the target CRP to bio-SPCE. A
value of n = 0.57 indicated a negative cooperativity in CRP binding thereby inhibiting the
multiple bonding of CRP antigen to a small aggregate/cluster of anti-CRP on the bio-SPCE
surface, possibly due to steric hindrance. The offset parameter Z = 0.69 ± 0.45 was in well
agreement with the measured bio-SPCE response to the pure buffer (ΔΦ = 0.43 ± 0.15),
shown by the dotted line in Fig. 7. The response results obtained from a collection of five bio-
SPCE revealed a clear differentiation between the pure buffer (ΔΦ = 0.43 ± 0.15) and the
buffer containing 10 ng mL−1 (84 pM) target CRP (ΔΦ = 1.1 ± 0.6°), which is about 2.5 times
higher for CRP analyte than a pure buffer. This sensitivity of the lowest detection of CRP
concentration is sufficient for clinical practice or point of care assay and is better than those
reported recently [34, 35]. Similar experiments were carried out with multiple controls with
pure PBS; negative control without anti-CRP functionalized SPCE and non-specific antigen
Mb and responses were compared with respect to specific target antigen CRP, under identical
Fig. 7 Calibration curve of bio-SPCE showing changes in phase angle as a function of CRP concentration. The
data are fit to a model based on Hill-Langmuir equation (red curve). Inset: Multiple control response of a bio-
SPCE for PBS buffer; b negative control (PyNHS/rGO/SPCE without anti-CRP) for 1 μg mL−1 CRP; c bio-
SPCE for non-specific 1 μg mL−1 Mb; and d bio-SPCE for specific 1 μg mL−1 CRP
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condition, and the results are shown in the inset of Fig. 7. The response (ΔΦ = 0.53 ± 0.11°)
obtained for 1 μg mL−1 non-specific myoglobin (cMb) is comparable to the pure buffer
response (ΔΦ = 0.43 ± 0.15°) but is far below the response (ΔΦ = 4.2 ± 0.1°) obtained for
the same concentration of specific CRP, suggesting a negligible contribution of response from
non-specific binding. This was further confirmed with a negative control that showed a
response (ΔΦ = 0.5 ± 0.1°) nearly comparable to a pure buffer, predicting a good specificity
for CRP. The bio-SPCE stability in solution was also investigated with at least six repeated
response measurements for a fixed sample concentration of 1.0 μg mL−1 CRP, which falls
within the acceptable range of consistent response demonstrating a good stability.
Conclusion
We demonstrate an antibody functionalized reduced graphene oxide deposited SPCE, as an
impedance immunosensor, for highly sensitive and specific quantification of CRP. The
graphene with a large surface area was used as an effective transducer for covalent immobi-
lization of a bioreceptor. The analytical performance of the proposed bioelectrode was then
assessed in terms of both sensitivity and specificity using single frequency analysis. The SFA
technique utilized in this study is fairly sensitive to electrical change occurring at the bio-SPCE
surface and allowed sensitive determination of change in phase angle with time. The bio-SPCE
exhibited a concentration-dependent response in the range of 10 ng mL−1 to 10 μg mL−1 CRP
in PBS which fall well in agreement to Hill-Langmuir equation of equilibrium thermodynam-
ics. This range of detection is much wider than other disposable biosensors recently reported
for CRP [12, 13, 35] and advantageous over a few others designed with other EIS methods
[14, 34, 35] due to its simple, cost-effective, disposable, and on-site analysis features. These
results indicate that the SFA electrochemical analysis of the anti-CRP-PyBu/rGO/SPCE may
provide a cost-effective point-of-care diagnosis tool for the sensitive detection of CRP after
suitable optimization with real clinical sample.
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